Cargando…

Development of Federally Mandated Risk Evaluation and Mitigation Strategies (REMS) for Transmucosal Immediate-Release Fentanyl Products

Detalles Bibliográficos
Autores principales:	Pergolizzi, Joseph V, Gharibo, Christopher G, Gudin, Jeffrey A, Nalamachu, Srinivas R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3666085/ https://www.ncbi.nlm.nih.gov/pubmed/23464790 http://dx.doi.org/10.1111/papr.12040

Ejemplares similares

Association of a Risk Evaluation and Mitigation Strategy Program With Transmucosal Fentanyl Prescribing
por: Fleischman, William, et al.
Publicado: (2019)

Safety and Efficacy of Oral Transmucosal Fentanyl Citrate Compared to Morphine Sulphate Immediate Release Tablet in Management of Breakthrough Cancer Pain
por: Bhatnagar, Sushma, et al.
Publicado: (2014)

Characteristics of Analgesic Patch Formulations
por: Nalamachu, Srinivas, et al.
Publicado: (2020)

Fentanyl transmucosal tablets: current status in the management of cancer-related breakthrough pain
por: Prommer, Eric, et al.
Publicado: (2012)

Oral transmucosal fentanyl citrate in cancer pain management: a practical application of nanotechnology
por: Mystakidou, Kyriaki, et al.
Publicado: (2007)

Efficacy of Oral Transmucosal Fentanyl Citrate for Premedication in Patients for Surgery under General Anesthesia
por: Singh, Raj Bahadur, et al.
Publicado: (2017)

Oral transmucosal fentanyl citrate analgesia in prehospital trauma care: an observational cohort study
por: Pietsch, Urs, et al.
Publicado: (2023)

An Evaluation of Total Disintegration Time for Three Different Doses of Sublingual Fentanyl Tablets in Patients with Breakthrough Pain
por: Nalamachu, Srinivas
Publicado: (2013)

The changing landscape of opioid prescribing: long-acting and extended-release opioid class-wide Risk Evaluation and Mitigation Strategy
por: Gudin, Jeffrey A
Publicado: (2012)

Tolperisone for the Treatment of Acute Muscle Spasm of the Back: Results from the Dose-Ranging Phase 2 STAR Study (NCT03802565)
por: Nalamachu, Srinivas, et al.
Publicado: (2020)

Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain
por: Mercadante, S, et al.
Publicado: (2007)

A new transmucosal drug delivery system for patients with breakthrough cancer pain: the fentanyl effervescent buccal tablet
por: Freye, Enno
Publicado: (2008)

Federally mandating motorcycle helmets in the United States
por: Eltorai, Adam E. M., et al.
Publicado: (2016)

Immediate release fentanyl in general practices: Mostly off-label prescribing
por: Weesie, Yvette M., et al.
Publicado: (2023)

Opioid rotation with extended-release opioids: where should we begin?
por: Nalamachu, Srinivas
Publicado: (2011)

The impact of the repeal of the federal individual insurance mandate on uninsurance
por: Soni, Aparna
Publicado: (2022)

COVID-19 Vaccine Mandates: Impact on Radiology Department Operations and Mitigation Strategies
por: Poyiadji, Neo, et al.
Publicado: (2022)

Silica Nanoparticles in Transmucosal Drug Delivery
por: M. Ways, Twana Mohammed, et al.
Publicado: (2020)

An open-label clinical trial of oral transmucosal haloperidol and oral transmucosal olanzapine in the treatment of terminal delirium at home
por: Lyu, Xiao-Juan, et al.
Publicado: (2022)

Implications of Risk Evaluation and Mitigation Strategy (REMS) Programs for Managed Care Pharmacy
por: Projects, AMCP Special
Publicado: (2012)

The system of coercive (court mandated) medical measures in the Russian Federation
por: Dianov, Dmitry, et al.
Publicado: (2007)

Effectiveness and Safety of Once-Daily Extended-Release Hydrocodone in Individuals Previously Receiving Immediate-Release Oxycodone for Chronic Pain
por: Pergolizzi, Joseph, et al.
Publicado: (2018)

Feasibility of a transmucosal sublingual fentanyl tablet as a procedural pain treatment in colonoscopy patients: a prospective placebo-controlled randomized study
por: Fihlman, Mari, et al.
Publicado: (2020)

Pharmacokinetic Characterisation and Comparison of Bioavailability of Intranasal Fentanyl, Transmucosal, and Intravenous Administration through a Three-Way Crossover Study in 24 Healthy Volunteers
por: Nardi-Hiebl, S., et al.
Publicado: (2021)

Transmucosal Absorption Enhancers in the Drug Delivery Field
por: Maher, Sam, et al.
Publicado: (2019)

The Potential of Films as Transmucosal Drug Delivery Systems
por: de Carvalho, Ana Clara Wada, et al.
Publicado: (2023)

Fast-Acting Sublingual Zolpidem for Middle-of-the-Night Wakefulness
por: Pergolizzi, Joseph V., et al.
Publicado: (2014)

Adherence to risk evaluation and mitigation strategies (REMS) requirements for monthly testing of liver function
por: Blanchette, Christopher M, et al.
Publicado: (2015)

Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter Study
por: Cuomo, Arturo, et al.
Publicado: (2020)

Illicitly Manufactured Fentanyl Entering the United States
por: Pergolizzi, Joseph, et al.
Publicado: (2021)

Peripheral Nerve Stimulation for Treatment of Cluneal Neuropathy Case Study
por: Soteropoulos, Costa, et al.
Publicado: (2022)

Effectiveness of Risk Evaluation and Mitigation Strategies (REMS) for Lenalidomide and Thalidomide: Patient Comprehension and Knowledge Retention
por: Brandenburg, Nancy A., et al.
Publicado: (2017)

Application of human factors engineering (HFE) to the design of a naloxone auto-injector for the treatment of opioid emergencies
por: Raffa, Robert B., et al.
Publicado: (2016)

Local, state and federal face mask mandates during the COVID-19 pandemic
por: Guzman-Cottrill, Judith A., et al.
Publicado: (2021)

Pharmacokinetics of Fentanyl Sublingual Spray in Opioid-Naïve Participants: Results of a Phase 1, Multiple Ascending Dose Study
por: Rauck, Richard L., et al.
Publicado: (2018)

A Randomized, Open-Label, Bioequivalence Study of Lidocaine Topical System 1.8% and Lidocaine Patch 5% in Healthy Subjects
por: Gudin, Jeffrey, et al.
Publicado: (2020)

Transmucosal Delivery of Nicotine in Combination with Tincture of Benzoin Inhibits Apoptosis
por: Battaglia, Alex, et al.
Publicado: (2017)

Preliminary Study for the Preparation of Transmucosal or Transdermal Patches with Acyclovir and Lidocaine
por: Marioane, Cristina-Adela, et al.
Publicado: (2021)

Transmucosal Buprenorphine in the Treatment of Dyspnea: Case Series and Review of the Literature
por: Blumenfeld-Kouchner, François, et al.
Publicado: (2021)

Stimuli-Responsive Polymers for Transdermal, Transmucosal and Ocular Drug Delivery
por: Berillo, Dmitriy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ec7o49sd1n8ft2aekmjrjek5sn